AI assistant
Moderna, Inc. — Director's Dealing 2025
Dec 1, 2025
30610_dirs_2025-12-01_12068666-02e6-464b-98b3-c4499f9e4e90.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-11-26
Reporting Person: Klinger Shannon Thyme (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-26 | Common Stock | M | 773 | — | Acquired | 28943 | Direct |
| 2025-11-26 | Common Stock | F | 374 | $24.75 | Disposed | 28569 | Direct |
| 2025-11-28 | Common Stock | M | 329 | — | Acquired | 28898 | Direct |
| 2025-11-28 | Common Stock | F | 160 | $25.01 | Disposed | 28738 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | Restricted Stock Units | $ | M | 773 | Disposed | Common Stock (773) | Direct | |
| 2025-11-28 | Restricted Stock Units | $ | M | 329 | Disposed | Common Stock (329) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.